Altogether, these results indicated that RIPK1 and TLR3 are frequently expressed in CCA patients and patients with high TLR3 and high RIPK1 display a trend for a longer DFS that raise the possibility toward the therapeutic development targeting TLR3 signaling in combination with Smac mimetic. This evidence concerns the gene TLR3 and cholangiocarcinoma.